JMP Securities Keeps Their Buy Rating on Evolent Health (EVH)
JMP Securities analyst Constantine Davides maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of ...
JMP Securities Remains a Hold on Globus Medical (GMED)
In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Globus Medical (GMED – Research Report). The ...
Keefe, Bruyette & Woods Issues Pessimistic Forecast for MFA Financial (NYSE:MFA) Stock Price
MFA Financial (NYSE:MFA – Get Free Report) had its price objective cut by equities researchers at Keefe, Bruyette & Woods from $13.50 to $12.50 in a note issued to investors on Thursday,Benzinga ...
Block's 'neighborhood network' draws mixed reviews
The payments company, which is unifying parts of its operation to deepen its reach with consumers and businesses, saw its stock fall more than 10% after reporting mixed earnings, though analysts are ...
Principal Securities Inc. Cuts Stock Position in Tyler Technologies, Inc. (NYSE:TYL)
Principal Securities Inc. lessened its stake in shares of Tyler Technologies, Inc. (NYSE:TYL – Free Report) by 2.3% in the ...
US FDA approves Mirum Pharma's genetic disorder drug
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...